Nuzenio

Pluvicto

Pluvicto news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 24 latest news signals 23 publisher sources 100/100 entity strength

Latest news

FDA approves Pluvicto for PSMA+ metastatic hormone-sensitive prostate cancer (mHSPC), advancing potential new standard of care across metastatic disease - NovartisNovartis · Sat, 08 Aug 2026 12:24:46 GMT St. Joseph’s Health offers Pluvicto treatment for patients with advanced prostate cancer - ROI-NJROI-NJ · Fri, 07 Aug 2026 17:00:15 GMT Approval of Pluvicto® for Metastatic Hormone-Sensitive Prostate Cancer - Oliver Sartor - urotoday.comurotoday.com · Thu, 06 Aug 2026 19:44:56 GMT FDA Expands Approval of Pluvicto® for Metastatic Prostate Cancer: Targets a Protein Called PSMA - Memorial Sloan Kettering Cancer CenterMemorial Sloan Kettering Cancer Center · Thu, 06 Aug 2026 04:00:00 GMT FDA Approved Pluvicto Plus ARPI for PSMA-Positive mAPMN/S Prostate Cancer - OncodailyOncodaily · Wed, 05 Aug 2026 10:28:25 GMT FDA Approves Pluvicto for Earlier Use in Prostate Cancer - SurvivorNetSurvivorNet · Tue, 04 Aug 2026 17:34:02 GMT FDA Approves Pluvicto for Early-Stage Metastatic Prostate Cancer - WebMDWebMD · Mon, 03 Aug 2026 23:11:02 GMT FDA Approves Lutetium Lu 177 for Earlier-Stage Prostate Cancer - The American Journal of Managed CareThe American Journal of Managed Care · Mon, 03 Aug 2026 17:37:08 GMT

Timeline

Sat, 08 Aug 2026 12:24:46 GMTFDA approves Pluvicto for PSMA+ metastatic hormone-sensitive prostate cancer (mHSPC), advancing potential new standard of care across metastatic disease - Novartis

Fri, 07 Aug 2026 17:00:15 GMTSt. Joseph’s Health offers Pluvicto treatment for patients with advanced prostate cancer - ROI-NJ

Thu, 06 Aug 2026 19:44:56 GMTApproval of Pluvicto® for Metastatic Hormone-Sensitive Prostate Cancer - Oliver Sartor - urotoday.com

Thu, 06 Aug 2026 04:00:00 GMTFDA Expands Approval of Pluvicto® for Metastatic Prostate Cancer: Targets a Protein Called PSMA - Memorial Sloan Kettering Cancer Center

Wed, 05 Aug 2026 10:28:25 GMTFDA Approved Pluvicto Plus ARPI for PSMA-Positive mAPMN/S Prostate Cancer - Oncodaily

Tue, 04 Aug 2026 17:34:02 GMTFDA Approves Pluvicto for Earlier Use in Prostate Cancer - SurvivorNet

Related explainers

HealthHealth stories help readers understand public-health signals, medical research, hospital systems, medicines, disease updates, and safety guidance.HealthcareHealthcare stories can affect personal decisions, so Nuzenio treats them as information that should be checked with original sources and professionals.ElectionsElection stories need careful handling because polls, turnout, legal challenges, and campaign claims can change quickly.

Connected entities

PSMA14 live mentions FDA10 live mentions Novartis9 live mentions Metastatic Prostate Cancer6 live mentions S Prostate Cancer6 live mentions Sensitive Prostate Cancer4 live mentions Positive4 live mentions FDA Approves Pluvicto4 live mentions ARPI4 live mentions Approval3 live mentions

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Pluvicto.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

23 distinct publisher/source names are currently connected to this entity page.